IP Library Granted Patent US 7,886,749
Granted Patent B2
US 7,886,749 · App. 11/429,698 · Granted Feb 15, 2011

Treatment of skin disorders with UV light and cooling

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,886,749
App. No.
11/429,698
Granted
Feb 15, 2011
Kind
B2
Abstract

Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of TV light can therefore be employed without injurious affects.

Claims (36)

1. A method for treating an epidermal region, the method comprising:

cooling the epidermal region to below about 0° C.; and

exposing the epidermal region to a dosage of ultraviolet light between about 6 and 20 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

2. The method of claim 1 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

3. The method of claim 1 , wherein cooling comprises spraying the epidermal region with a cool liquid, gas, or air.

4. The method of claim 1 , wherein cooling comprises contacting the epidermal region with a chilled surface.

5. The method of claim 1 , wherein the epidermal region is cooled to below about −5° C.

6. The method of claim 1 , further comprising determining the MED of a patient having said epidermal tissue.

7. A method for treating an epidermal region, the method comprising:

cooling the epidermal region to below about 5° C.; and

exposing the epidermal region to a dosage of ultraviolet light between about 6 and 20 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

8. The method of claim 7 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

9. The method of claim 7 , wherein cooling comprises spraying the epidermal region with a cool liquid, gas, or air.

10. The method of claim 7 , wherein cooling comprises contacting the epidermal region with a chilled surface.

11. The method of claim 7 , further comprising determining the MED of a patient having said epidermal tissue.

12. A method for treating an epidermal region, the method comprising:

cooling the epidermal region to a temperature lower than normal temperature of the skin; and

exposing the epidermal region to a dosage of ultraviolet light between about 6 and 20 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

13. The method of claim 12 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

14. The method of claim 12 , wherein cooling comprises spraying the epidermal region with a cool liquid, gas, or air.

15. The method of claim 12 , wherein cooling comprises contacting the epidermal region with a chilled surface.

16. The method of claim 12 , further comprising determining the MED of a patient having said epidermal tissue.

17. A method for treating an epidermal region, the method comprising:

cooling the epidermal region to a temperature lower than normal temperature of the skin; and

exposing the epidermal region to a dosage of ultraviolet light between about 8 and 20 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

18. The method of claim 17 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

19. The method of claim 17 , wherein cooling comprises spraying the epidermal region with a cool liquid, gas, or air.

20. The method of claim 17 , wherein cooling comprises contacting the epidermal region with a chilled surface.

21. The method of claim 17 , further comprising determining the MED of a patient having said epidermal tissue.

22. A method for treating an epidermal region, the method comprising:

cooling the epidermal region to a temperature lower than normal temperature of the skin; and

exposing the epidermal region to a dosage of ultraviolet light equal to or greater than about 16 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

23. The method of claim 22 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

24. The method of claim 22 , wherein cooling comprises spraying the epidermal region with a cool liquid, gas, or air.

25. The method of claim 22 , wherein cooling comprises contacting the epidermal region with a chilled surface.

26. The method of claim 22 , further comprising determining the MED of a patient having said epidermal tissue.

Assignments (8)
SECURITY INTEREST Recorded Oct 6, 2021
From: STRATA SKIN SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 057717/0796 →
RELEASE OF SECURITY INTEREST Recorded Jan 20, 2020
From: MIDCAP FINANCIAL TRUST
To: STRATA SKIN SCIENCES, INC.
Reel/Frame 051558/0510 →
CHANGE OF NAME Recorded May 30, 2018
From: MELA SCIENCES, INC.
To: STRATA SKIN SCIENCES, INC.
Reel/Frame 046264/0285 →
SECURITY INTEREST Recorded Dec 31, 2015
From: MELA SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037391/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2015
From: PHOTOMEDEX TECHNOLOGY, INC.
To: MELA SCIENCES, INC.
Reel/Frame 036236/0243 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 3, 2015
From: PHOTOMEDEX, INC.
To: PHOTOMEDEX TECHNOLOGY, INC.
Reel/Frame 036236/0201 →
RELEASE OF SECURITY INTEREST Recorded Jun 23, 2015
From: JPMORGAN CHASE BANK, N.A.
To: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
Reel/Frame 036007/0222 →
SECURITY INTEREST Recorded May 14, 2014
From: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032892/0586 →